Cubist said it would pay Optimer shareholders $10.75 a share in cash upfront, and an additional $5 a share contingent on Optimer’s meeting certain sales milestones. The total value of $15.75 a share is a premium of about 19 percent to Optimer’s closing price of $13.29 on Tuesday,…
Source:Antibiotics Maker in Deals for 2 Rivals
Tuesday, July 30, 2013
Antibiotics Maker in Deals for 2 Rivals
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment